Mutagen treatment of mouse mastocytoma P815 produces highly immunogenic "turn-" variants. Most of these variants express potent transplantation antigens which are not present on the original P815 tumor cells. These tum-antigens, which appear to be specific for each variant, elicit a strong cytolytic
β¦ LIBER β¦
Increased frequency of immunogenic variants obtained by repeated mutagen treatment of mouse mastocytoma P815
β Scribed by Boon, Thierry; Marchand, Marie; Caspar, Philippe
- Book ID
- 122824058
- Publisher
- Elsevier Science
- Year
- 1983
- Weight
- 996 KB
- Volume
- 19
- Category
- Article
- ISSN
- 0277-5379
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Immunogenic (tumβ) variants obtained by
β
Thomas WΓΆlfel; Aline Pel; Etienne Plaen; Christophe Lurquin; Janet L. Maryanski;
π
Article
π
1987
π
Springer-Verlag
π
English
β 1020 KB
Immunogenic variants obtained by mutagen
β
Jacques van Snick; Janet Maryanski; Aline Van Pel; Giorgio Parmiani; Thierry Bon
π
Article
π
1982
π
John Wiley and Sons
π
English
β 427 KB
Immunogenic variants obtained by mutagen
β
Janet L. Maryanski; Josiane Szpirer; Claude Szpirer; Thierry Boon
π
Article
π
1983
π
Springer
π
English
β 645 KB
Immunogenic variants obtained by mutagen
β
Janet L. Maryanski; Jacques Van Snick; Jean-Charles Cerottini; Thierry Boon
π
Article
π
1982
π
John Wiley and Sons
π
English
β 666 KB
Immunogenic variants obtained by mutagen
β
J. L. Maryanski; M. Marchand; C. Uyttenhove; T. Boon
π
Article
π
1983
π
John Wiley and Sons
π
French
β 504 KB
## Abstract After mutagenesis of mouse mastocytoma P815, it is possible to obtain variant (tum^β^) clones that are almost always rejected by syngeneic DBA/2 mice. Most tum^β^ clones express new variantβspecific antigens that can be detected by cytolytic T cells (CTL). Occasionally, mice injected wi
Tum variants: immunogenic variants obtai
β
Thierry Boon
π
Article
π
1985
π
Elsevier Science
π
English
β 847 KB